About US
Kannavis iTrade: Value Chain Specialist’s connecting the industry from Hemp Biomass to Medical Cannabis.
Review and analyze your companies value in integrated supply chain.
We close contracts with 0% compensation attached. We exepdiate your group to profitability and, help your bottom-line.
We create multi-tier value from seed to sale.
Matching buyers and sellers for curated batches of craft flower under Health Canada license (GACP, GPP) , CUMCS , and EU-GMP post-harvest licenses under short- and long-term agreements.
Our group can produce small batches of curated flower, to scalable dried craft flower on a weekly basis.
Canada cannabis sales rises to 4 billion, 25 billion in USA, 2 billion in Germany in 2022. Cannabis is now the 6th most valuable crop in USA.
There is a global over supply of inferior mass-produced cannabis. Greater demand now than ever for craft cannabis from small batch producers.
Disconnect from producers to end clients. We vet out all groups and pivot them in supply chain to help bottom-line and achieve profitability sooner.
Trends & Growth
| 26.6 Billion | Hemp biomass (only CBD) projected sales by 2025 CAGR of 34% |
| 82 Billion | Medical Cannabis alone projected sales by 2027 CAGR of 20.25% |
| 146 Billion | Recreational and medical cannabis projected sales by 2025 |
Trends & Growth
| 26.6 Billion | Hemp biomass (only CBD) projected sales by 2025 CAGR of 34% |
| 82 Billion | Medical Cannabis alone projected sales by 2027 CAGR of 20.25% |
| 146 Billion | Recreational and medical cannabis projected sales by 2025 |
Our Solutions
Kannavis iTrade
0% compensation as you're advisor
• Strategic advisor
• Restoration cultivation group
• Consultant, business advisor
• Finance group.
• Offering offtake agreements.
• Restoration cultivation group
• Consultant, business advisor
• Finance group.
• Offering offtake agreements.
Kannavis iREC
Recreational Cannabis
• Our groups review licensed producers to ensure they are 100% craft for rec market.
• Our group reviews end distribution points to ensure a seamless supply chain.
• We advise, offer, and present curated stabilized genetics for the rec market.
• Our group can offer small batches to controlled dried flower on weekly basis.
• Our group reviews end distribution points to ensure a seamless supply chain.
• We advise, offer, and present curated stabilized genetics for the rec market.
• Our group can offer small batches to controlled dried flower on weekly basis.
Kannavis iMed
Medical Cannabis
• We curate small batches of craft flower for CUMCS and EU-GMP markets.
• We offer education to physicians, genetics, controlled cultivation, and offtake agreements.
• Our group still grows for medical patients in Canada under ACMPR personal access program.
• We align physicians, nursery, cultivation team, and constant feedback loop holistic care.
• We work alongside established medical supply clinics with minimum 5 years of service NOT in cannabis industry. Separating "cannabis influencing clinic" from Health and wellness clinics.
• We are the alternative to pharmaceutical care.
• We base our practice on a holistic approach, rather than prescribing on symptoms only.
• We offer education to physicians, genetics, controlled cultivation, and offtake agreements.
• Our group still grows for medical patients in Canada under ACMPR personal access program.
• We align physicians, nursery, cultivation team, and constant feedback loop holistic care.
• We work alongside established medical supply clinics with minimum 5 years of service NOT in cannabis industry. Separating "cannabis influencing clinic" from Health and wellness clinics.
• We are the alternative to pharmaceutical care.
• We base our practice on a holistic approach, rather than prescribing on symptoms only.
location
Canada
Location T.O.
Available Area 1500 m 2
Our company's head office is located in Toronto, Canada.
